ConformationX Therapeutics
Canton, US · Founded 2019 · Delaware LLC
Find your way into ConformationX Therapeutics
Sign up to see every warm intro you have to ConformationX Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ConformationX Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
TT
Tony TannouryNamed on SEC filing
VC
Vipul ChitaliaNamed on SEC filing
AM
Ali MunawarNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$4.6M disclosed across 1 round · 2019
▶$4.6MraisedJul 2019 · 4 investors · BiotechnologyRule 506(b)
▶$4.6MraisedJul 2019 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tony TannouryDirector
- Vipul ChitaliaExecutive Officer, Director, Promoter
- Ali MunawarExecutive Officer, Director, Promoter
- Offering amount
- $7M
- Amount sold
- $4.6M
- First sale
- Jun 2019
- Incorporated
- Limited Liability Company, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ConformationX Therapeutics raised?
- ConformationX Therapeutics has disclosed $4.6M raised across 1 round.
- Where is ConformationX Therapeutics headquartered?
- ConformationX Therapeutics is headquartered in Canton, US.